This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Use transparent tracking, peer checks, and clear milestones to build accountability into your everyday budgeting routine.
17,869 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Palantir stock sits at a valuation well above the market average. This piece breaks down what that 2,500% gap means, ...
Investors are looking at SMH with fresh eyes as AI infrastructure expands. This article explains why a bold predictio...
Lawmakers face a looming funding gap in Social Security, with projections of trust fund depletion by the early 2030s....
As AI demand accelerates, one company stands out for investors: TSMC. This article explains why the so-called tsmc mo...
Unisys (UIS) 2026 earnings could hinge on services growth, margin discipline, and backlog strength. This guide breaks...
Could buying oklo stock spark a life-changing return, or is it a high-stakes gamble? This guide breaks down what the ...
AI growth is fueling demand for data infrastructure, but investors still want reliable income. This article explains ...
Rocket Lab stock has hit an all-time high, but savvy investors know a rally is more than a headline. This guide break...
A large fund sold a sizable stake, and the stock still lagged the market. This look breaks down what happened, why it...
The Roundhill Magnificent Seven ETF (MAGS) now provides one-ticker exposure to seven mega-cap AI leaders. It uses equ...
Arm stock skyrocketed this week as AI enthusiasm and licensing momentum collided with bullish analyst coverage. This ...